FMAMX
Price
$79.58
Change
+$0.94 (+1.20%)
Updated
Jun 6 closing price
Net Assets
6.86B
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

FMAMX vs VITSX

Header iconFMAMX vs VITSX Comparison
Open Charts FMAMX vs VITSXBanner chart's image
Fidelity Advisor Stock Sel A
Price$79.58
Change+$0.94 (+1.20%)
VolumeN/A
Net Assets6.86B
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
FMAMX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FMAMX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMAMX is a Buy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. FMAMX (6.86B). VITSX pays higher dividends than FMAMX: VITSX (1.29) vs FMAMX (0.51). FMAMX was incepted earlier than VITSX: FMAMX (13 years) vs VITSX (28 years). FMAMX (0.73) is less costly to investors than VITSX (0.03). FMAMX is a more actively managed with annual turnover of: 3.00 vs. VITSX (2.00). FMAMX has a lower initial minimum investment than VITSX: FMAMX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. FMAMX (5.56). VITSX return over 5 years is better than : 80.96 vs. FMAMX (64.47).
FMAMXVITSXFMAMX / VITSX
Total Expense Ratio0.730.032,433%
Annual Report Gross Expense Ratio0.730.032,433%
Fund Existence13 years28 years-
Gain YTD-0.0250.833-3%
Front Load6%N/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.86B1.82T0%
Annual Yield % from dividends0.511.2940%
Returns for 1 year5.5610.9751%
Returns for 3 years33.5840.3583%
Returns for 5 years64.4780.9680%
Returns for 10 years117.77180.4965%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.